Kamada Reports Q1 2026 Results, Reaffirms Strong Annual Guidance Despite Temporary Shipment Delay

summarizeSummary

Kamada reported Q1 2026 financial results, showing modest growth impacted by a temporary shipment delay, but reaffirmed its strong annual guidance for 2026, signaling confidence in future performance.

check_boxKey Events

• Q1 2026 Financial Results

  Total revenues were $45.2 million, a 3% increase year-over-year. Net income was $4.1 million, up 4% year-over-year, with diluted EPS at $0.07. Adjusted EBITDA remained flat at $11.6 million.

• Temporary Shipment Delay Impact

  First-quarter results were affected by a temporary shipment delay of a single order, which was subsequently delivered during April, suggesting underlying demand remains strong.

• 2026 Annual Guidance Reaffirmed

  Kamada reaffirmed its full-year 2026 guidance, expecting total revenues in the range of $200 million to $205 million and adjusted EBITDA between $50 million and $53 million, representing double-digit organic profitable growth.

• Strategic Growth Pillars

  The company continues to focus on expanding its commercial product portfolio, ramping up plasma collection operations, and evaluating new business development and M&A opportunities.

auto_awesomeAnalysis

Kamada's first-quarter results showed modest revenue and net income growth, with flat adjusted EBITDA, primarily due to a temporary shipment delay that was resolved in April. Despite this, the company reaffirmed its full-year 2026 guidance for significant revenue and adjusted EBITDA growth, indicating confidence in a stronger performance for the remainder of the year. This update provides investors with the first look at performance against the previously issued annual guidance.